Squarepoint
NVAX icon

Squarepoint’s Novavax NVAX Stock Holding History

Squarepoint’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,100
Closed -$243K – 4736
2025
Q4 		$243K Hold
36,100
– – ﹤0.01% 3755
2025
Q3 		$313K Hold
36,100
– – ﹤0.01% 3624
2025
Q2 		$227K Hold
36,100
– – ﹤0.01% 3898
2025
Q1 		$231K Sell
36,100
-131,300
-78% -$1.09M ﹤0.01% 3918
2024
Q4 		$1.35M Buy
167,400
+151,600
+959% +$1.46M ﹤0.01% 2784
2024
Q3 		$200K Buy
+15,800
New +$204K ﹤0.01% 3689
2022
Q1 		– Sell
-9,300
Closed -$1.33M – 3311
2021
Q4 		$1.33M Hold
9,300
– – ﹤0.01% 1514
2021
Q3 		$1.93M Sell
9,300
-14,800
-61% -$3.26M 0.01% 1220
2021
Q2 		$5.12M Buy
+24,100
New +$4.42M 0.02% 717

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Squarepoint's NVAX Position: Q2 2026 in Review

Squarepoint opened a new position in Novavax (NVAX) in Q2 2026: 133,562 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #2721 among its holdings. This is a return to the name: Squarepoint previously reported a position in NVAX as recently as Q2 2025.

Squarepoint first reported a position in NVAX in Q3 2015 and has held it in 27 quarters since. The position peaked at $11.6M in Q2 2022. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Squarepoint held 133,562 shares of Novavax worth $1.26M as of Q2 2026.
  • Novavax was a new Squarepoint position in Q2 2026.
  • Novavax made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2721 holding.
  • Squarepoint first reported a position in Novavax in Q3 2015 and has held it in 27 quarters since.
  • Squarepoint's Novavax position peaked at $11.6M in Q2 2022.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.